- Home
- TILE vs INBX Comparison
TILE vs INBX Comparison
Compare TILE & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TILE | INBX |
|---|---|---|
| Founded | 1973 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 1994 | 2024 |
Fundamental Metrics
Financial Performance| Metric | TILE | INBX |
|---|---|---|
| Price | $28.89 | $95.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $36.00 | ★ $150.00 |
| AVG Volume (30 Days) | ★ 517.8K | 415.9K |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | ★ 0.29% | N/A |
| EPS Growth | ★ 32.43 | N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $1,386,854,000.00 | $1,300,000.00 |
| Revenue This Year | $6.72 | N/A |
| Revenue Next Year | $5.61 | N/A |
| P/E Ratio | $71.95 | ★ N/A |
| Revenue Growth | 5.41 | ★ 550.00 |
| 52 Week Low | $20.01 | $13.11 |
| 52 Week High | $35.11 | $155.29 |
Technical Indicators
Market Signals| Indicator | TILE | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 52.05 | 40.29 |
| Support Level | $26.60 | $71.31 |
| Resistance Level | $28.89 | $153.14 |
| Average True Range (ATR) | 1.02 | 8.69 |
| MACD | -0.02 | -3.15 |
| Stochastic Oscillator | 58.14 | 17.62 |
Price Performance
Historical ComparisonAbout TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment. Its products include: ESD, Acoustic, Extreme Wear, and Quick Installation System (nTx).
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.